Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Oxygen pressure in African Americans
Lucentis not approved by NICE
SS-OCT and choroidal thickness
Pfizer withdraws application
Survey

Would you use tacrolimus eye drops for refractory vernal keratoconjunctivitis?

YES
69%
NO
31%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

July 27, 2011
Partial pressure of oxygen is significantly higher in African American patients
Ocular oxygen levels are higher in African American patients than in Caucasians. More...
Lucentis not recommended by NICE for treating DME in England and Wales
The National Institute for Health and Clinical Excellence (NICE) has not recommended Lucentis for the treatment of diabetic macular oedema (DME) for the English and Welsh NHS. More...
Event Profiles
Croma
During this year´s ESCRS in Vienna CROMA will highlight its history of 35 years as a key player in ophthalmology.

Read more...
Event Profiles
Moria
UT-DSAEK: the new Moria system allows creation of Ultra-thin planar corneal lamellar grafts by a 2-pass technique (Pr. Busin) with the ease of handling and preparation of conventional DSAEK. See us at ESCRS, booth B610.

Read more...
Event Profiles
OCULUS Optikgeräte GmbH
Premiere at OCULUS booth B614 in Vienna: The most exciting new Corvis® ST will be presented. The new device allows seeing the reaction of the cornea on an air impulse.

Read more...
SS-OCT system is successful in evaluating macular choroidal thickness
A study featured in Investigative Ophthalmology and Visual Science has demonstrated the accuracy of the swep-source optical coherence tomography (SS-OCT) system in evaluating choroidal thickness. More...
Pfizer withdraws extension of therapeutic indication for DME
Pfizer has notified the European Medicines Agency (EMA) that it will withdraw it's application for an extension on the therapeutic indication for Macugen. More...

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH. United Kingdom